Quitayen, Santiago C.

HRN: 27-68-15  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2025
CO-AMOXICLAV 625MG (TAB)
08/29/2025
09/05/2025
PO
625mg
TID
Typhoid Fever
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines